- Home
- APLD vs RNA Comparison
APLD vs RNA Comparison
Compare APLD & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLD
- RNA
- Stock Information
- Founded
- APLD 2001
- RNA 2012
- Country
- APLD United States
- RNA United States
- Employees
- APLD N/A
- RNA N/A
- Industry
- APLD Investment Bankers/Brokers/Service
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- APLD Finance
- RNA Health Care
- Exchange
- APLD Nasdaq
- RNA Nasdaq
- Market Cap
- APLD 9.3B
- RNA 4.0B
- IPO Year
- APLD N/A
- RNA 2020
- Fundamental
- Price
- APLD $30.95
- RNA $69.82
- Analyst Decision
- APLD Strong Buy
- RNA Buy
- Analyst Count
- APLD 11
- RNA 20
- Target Price
- APLD $29.36
- RNA $69.26
- AVG Volume (30 Days)
- APLD 32.1M
- RNA 9.8M
- Earning Date
- APLD 10-09-2025
- RNA 11-07-2025
- Dividend Yield
- APLD N/A
- RNA N/A
- EPS Growth
- APLD N/A
- RNA N/A
- EPS
- APLD N/A
- RNA N/A
- Revenue
- APLD $173,560,000.00
- RNA $10,729,000.00
- Revenue This Year
- APLD $113.90
- RNA N/A
- Revenue Next Year
- APLD $71.28
- RNA $108.97
- P/E Ratio
- APLD N/A
- RNA N/A
- Revenue Growth
- APLD 28.43
- RNA 1.23
- 52 Week Low
- APLD $3.31
- RNA $21.51
- 52 Week High
- APLD $40.20
- RNA $70.51
- Technical
- Relative Strength Index (RSI)
- APLD 49.27
- RNA 79.30
- Support Level
- APLD $29.95
- RNA $69.50
- Resistance Level
- APLD $33.90
- RNA $69.86
- Average True Range (ATR)
- APLD 3.10
- RNA 0.88
- MACD
- APLD -0.88
- RNA 0.81
- Stochastic Oscillator
- APLD 30.29
- RNA 91.19
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.